FLGC 1 (-1.96%)
CA3397641026Drug ManufacturersDrug Manufacturers - Specialty & Generic

Flora Growth (FLGC) Competitor Comparison

We are evaluating the key criteria listed to compare Flora Growth (FLGC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - FLGC ranking 44 / 54

These are the competitors of Flora Growth in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Amneal Pharmaceuticals AMRX
91.03
2. Kamada KMDA
41.35
3. Catalent CTLT
26.26
4. Supernus Pharmaceuticals SUPN
13.72
5. Alimera Sciences ALIM
11.95
6. Regencell Bioscience Holdings RGC
11.26
7. Evolus EOLS
9.31
8. Neoleukin Therapeutics NLTX
8.58
9. Pacira BioSciences PCRX
7.39
10. Vifor Pharma G2AB.F
7.23
11. ANI Pharmaceuticals ANIP
7.21
12. Relmada Therapeutics RLMD
6.91
13. Perrigo PRGO
6.18
14. Alvotech ALVO
5.74
15. ProPhase Labs PRPH
5.7
16. PetIQ PETQ
5.38
17. Ironwood Pharmaceuticals IRWD
5.14
18. Curaleaf Holdings CURLF
4.94
19. Kolinpharma KIP.MI
4.88
20. Zoetis ZTS
4.69
21. Green Thumb Industries R9U2.F
4.47
22. Ayr Wellness 3KJB.F
4.36
23. Phibro Animal Health PAHC
4.19
24. Elanco Animal Health ELAN
4.04
25. Linc LNC
3.79
26. Organogenesis Holdings ORGO
3.77
27. Taro Pharmaceutical Industries TARO
3.48
28. Emergent BioSolutions EBS
3.15
29. Procaps Group PROC
3.07
30. Bausch Health Companies BHC
2.91
31. Journey Medical DERM
2.86
32. Embecta EMBC
2.51
33. Eagle Pharmaceuticals EGRX
2.48
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Jupiter Wellness JUPW
2.39
36. Cumberland Pharmaceuticals CPIX
2.31
37. Societal CDMO SCTL
2.21
38. Solid Biosciences SLDB
2.13
39. Amphastar Pharmaceuticals AMPH
2
40. Clever Leaves Holdings CLVR
1.98
41. SCYNEXIS SCYX
1.97
42. Theratechnologies THTX
1.87
43. OptiNose OPTN
1.83
44. Flora Growth FLGC
1.78
45. Ascend Wellness Holdings AAWH
1.77
46. Cronos Group CRON
1.75
47. Biofrontera BFRI
1.74
48. Alpha Teknova TKNO
1.73
49. Universe Pharmaceuticals UPC
1.66
50. Tilray Brands TLRY
1.41
51. Collegium Pharmaceutical COLL
1.19
52. Teva Pharmaceutical Industries TEVA
1.13
53. Harrow Health HROW
0.75
54. Avadel Pharmaceuticals AVDL
0.46

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.